is semaglutide discontinued An Ongoing Crisis: Shortage Raises Dual Concerns for Obesity and Diabetes Treatment Research shows semaglutide — commonly

On average, PBMs help patients and employers save over $1,100 per person each year by negotiating drug prices On April 1, 2026, the FDA approved Eli Lillys Foundayo, the second oral GLP1 for weight loss offering fewer administration restrictions and achieving one of the fastest newdrug approvals in decades. On March 26, 2026, the FDA approved Awiqli (insulin icodec abae) from Novo Nordisk the first onceweekly basal insulin for adults with type 2 diabetes

During month -2, you work together to optimize insulin doses to achieve an A1C below 6.5% while minimizing hypoglycemia

Maintaining 30-50 grams of healthy fats daily prevents bile sludge formation during rapid weight loss

Respecting your own privacy boundaries while communicating clear needs results in professional cooperation